Royce & Associates’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-28,124
| Closed | -$920K | – | 1040 |
|
|
2021
Q3 | $920K | Sell |
28,124
-63,400
| -69% | -$2.32M | 0.01% | 830 |
|
|
2021
Q2 | $3.82M | Sell |
91,524
-8,957
| -9% | -$459K | 0.03% | 653 |
|
|
2021
Q1 | $6.57M | Buy |
100,481
+44,334
| +79% | +$3.09M | 0.04% | 544 |
|
|
2020
Q4 | $3.69M | Buy |
56,147
+3,277
| +6% | +$214K | 0.03% | 612 |
|
|
2020
Q3 | $2.87M | Buy |
52,870
+13,833
| +35% | +$1.06M | 0.03% | 606 |
|
|
2020
Q2 | $3.72M | Sell |
39,037
-2,906
| -7% | -$216K | 0.04% | 520 |
|
|
2020
Q1 | $2.15M | Buy |
41,943
+7,454
| +22% | +$779K | 0.03% | 576 |
|
|
2019
Q4 | $2.83M | Sell |
34,489
-1,500
| -4% | -$105K | 0.03% | 625 |
|
|
2019
Q3 | $3.08M | Buy |
35,989
+9,191
| +34% | +$981K | 0.03% | 605 |
|
|
2019
Q2 | $3.42M | Buy |
26,798
+1,148
| +4% | +$165K | 0.03% | 589 |
|
|
2019
Q1 | $4.63M | Sell |
25,650
-6,866
| -21% | -$993K | 0.04% | 521 |
|
|
2018
Q4 | $3.61M | Sell |
32,516
-2,141
| -6% | -$279K | 0.03% | 584 |
|
|
2018
Q3 | $4.68M | Buy |
34,657
+6,378
| +23% | +$879K | 0.03% | 611 |
|
|
2018
Q2 | $3.9M | Buy |
28,279
+2,600
| +10% | +$358K | 0.03% | 665 |
|
|
2018
Q1 | $3.54M | Buy |
25,679
+4,740
| +23% | +$645K | 0.02% | 670 |
|
|
2017
Q4 | $2.58M | Hold |
20,939
| – | – | 0.02% | 782 |
|
|
2017
Q3 | $2.86M | Sell |
20,939
-666
| -3% | -$101K | 0.02% | 741 |
|
|
2017
Q2 | $3.79M | Sell |
21,605
-2,350
| -10% | -$334K | 0.03% | 677 |
|
|
2017
Q1 | $2.88M | Sell |
23,955
-1,934
| -7% | -$201K | 0.02% | 753 |
|
|
2016
Q4 | $2.52M | Sell |
25,889
-1,900
| -7% | -$174K | 0.02% | 764 |
|
|
2016
Q3 | $2.61M | Sell |
27,789
-5,646
| -17% | -$566K | 0.02% | 738 |
|
|
2016
Q2 | $3.6M | Sell |
33,435
-20,773
| -38% | -$2.43M | 0.02% | 683 |
|
|
2016
Q1 | $6.5M | Buy |
54,208
+2,249
| +4% | +$236K | 0.04% | 526 |
|
|
2015
Q4 | $6.19M | Buy |
51,959
+12,267
| +31% | +$1.58M | 0.04% | 559 |
|
|
2015
Q3 | $6.76M | Sell |
39,692
-2,600
| -6% | -$498K | 0.04% | 569 |
|
|
2015
Q2 | $8.2M | Sell |
42,292
-8,000
| -16% | -$1.48M | 0.03% | 612 |
|
|
2015
Q1 | $7.45M | Sell |
50,292
-9,360
| -16% | -$1.43M | 0.03% | 662 |
|
|
2014
Q4 | $9.31M | Sell |
59,652
-3,946
| -6% | -$568K | 0.03% | 624 |
|
|
2014
Q3 | $9.12M | Sell |
63,598
-10,884
| -15% | -$1.58M | 0.03% | 638 |
|
|
2014
Q2 | $9.72M | Sell |
74,482
-950
| -1% | -$121K | 0.03% | 683 |
|
|
2014
Q1 | $9.23M | Buy |
75,432
+4,300
| +6% | +$466K | 0.03% | 701 |
|
|
2013
Q4 | $7.55M | Buy |
71,132
+11,367
| +19% | +$1.1M | 0.02% | 766 |
|
|
2013
Q3 | $6.71M | Buy |
59,765
+20,000
| +50% | +$2.27M | 0.02% | 784 |
|
|
2013
Q2 | $4.49M | Buy |
+39,765
| New | +$4.86M | 0.01% | 873 |
|
Other funds holding SRGA
CLG
EP
Royce & Associates's SRGA Position: Q4 2021 in Review
Royce & Associates sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2021, closing a stake of 28,124 shares — an estimated $920K sold.
Royce & Associates first reported a position in SRGA in Q2 2013 and held it in 34 quarters. The position peaked at $9.72M in Q2 2014. 72 funds tracked by Wall St. Rank hold SRGA as of Q4 2021.
- Royce & Associates reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
- Royce & Associates sold 28,124 Surgalign Holdings, Inc. Common Stock shares in Q4 2021, an estimated $920K.
- Royce & Associates first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 34 quarters.
- Royce & Associates's Surgalign Holdings, Inc. Common Stock position peaked at $9.72M in Q2 2014.
- 72 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2021.
Based on Royce & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.